share_log

阳光诺和(688621.SH)拟1.2亿元收购诺和晟泰30%股权至持有其全部股权

Sunshine Novo (688621.SH) plans to acquire 30% of Novo Shengtai's shares for 120 million yuan to hold all of its shares

Zhitong Finance ·  Oct 13, 2023 03:38

Zhitong Financial APP News, Sunlight Nuohe (688621.SH) announced that the company and its holding subsidiary Chengdu Nuohe Shengtai Biotechnology Co., Ltd. (hereinafter referred to as "Nuohe Shengtai") and Chengdu Shengpu Pharmaceutical Technology Center (limited partnership) (hereinafter referred to as "Shengpu Pharmaceutical") signed the "Chengdu Nuohe Shengtai Biotechnology Co., Ltd. Equity transfer Agreement" Shengpu Pharmaceutical plans to transfer its 30 per cent stake in Nuohe Shengtai to the company at 120 million yuan. After the completion of this transaction, Shengpu Pharmaceutical no longer holds the equity of Nuohe Shengtai, and the company holds 100% equity of Nuohe Shengtai.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment